{
  "symbol": "NTLA",
  "socialMediaRisk": {
    "hypeSusceptibility": true,
    "volatilityDrivenBy": ["biotechnology sector", "CRISPR technology", "small-cap market"],
    "riskScore": 7,
    "reason": "Intellia Therapeutics operates in the biotech sector with a focus on CRISPR technology, making it prone to speculative retail interest and social media hype."
  }
}